HuR is a post-transcriptional regulator of core metabolic enzymes in pancreatic cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HuR is a post-transcriptional regulator of core metabolic enzymes in pancreatic cancer
Authors
Keywords
-
Journal
RNA Biology
Volume 10, Issue 8, Pages 1312-1323
Publisher
Informa UK Limited
Online
2013-06-28
DOI
10.4161/rna.25274
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HuR’s post-transcriptional regulation of death receptor 5 in pancreatic cancer cells
- (2012) Danielle M. Pineda et al. CANCER BIOLOGY & THERAPY
- Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
- (2012) Paolo P. Provenzano et al. CANCER CELL
- Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
- (2012) Patrick S. Ward et al. CANCER CELL
- Glycine Decarboxylase Activity Drives Non-Small Cell Lung Cancer Tumor-Initiating Cells and Tumorigenesis
- (2012) Wen Cai Zhang et al. CELL
- Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
- (2012) Haoqiang Ying et al. CELL
- The Pancreas Cancer Microenvironment
- (2012) C. Feig et al. CLINICAL CANCER RESEARCH
- The mRNA-stabilizing Factor HuR Protein Is Targeted by β-TrCP Protein for Degradation in Response to Glycolysis Inhibition
- (2012) Po-Chen Chu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Comparative Metabolic Flux Profiling of Melanoma Cell Lines
- (2011) David A. Scott et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Integrative Regulatory Mapping Indicates that the RNA-Binding Protein HuR Couples Pre-mRNA Processing and mRNA Stability
- (2011) Neelanjan Mukherjee et al. MOLECULAR CELL
- Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
- (2011) Richard Possemato et al. NATURE
- Hypo- and hyperactivated Notch signaling induce a glycolytic switch through distinct mechanisms
- (2011) S. K.- J. Landor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome
- (2011) Z. J. Reitman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HuR Regulates -Tubulin Isotype Expression in Ovarian Cancer
- (2010) G. Raspaglio et al. CANCER RESEARCH
- Stromal biology and therapy in pancreatic cancer
- (2010) A. Neesse et al. GUT
- Metabolic and proteomic differentials in head and neck squamous cell carcinomas and normal gingival tissue
- (2010) Thomas Ziebart et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Distant metastasis occurs late during the genetic evolution of pancreatic cancer
- (2010) Shinichi Yachida et al. NATURE
- Metabolism and proliferation share common regulatory pathways in cancer cells
- (2010) V Fritz et al. ONCOGENE
- Posttranscriptional regulation of cancer traits by HuR
- (2010) Kotb Abdelmohsen et al. Wiley Interdisciplinary Reviews-RNA
- Integrated, Nontargeted Ultrahigh Performance Liquid Chromatography/Electrospray Ionization Tandem Mass Spectrometry Platform for the Identification and Relative Quantification of the Small-Molecule Complement of Biological Systems
- (2009) Anne M. Evans et al. ANALYTICAL CHEMISTRY
- The Role of HuR in Gemcitabine Efficacy in Pancreatic Cancer: HuR Up-regulates the Expression of the Gemcitabine Metabolizing Enzyme Deoxycytidine Kinase
- (2009) C. L. Costantino et al. CANCER RESEARCH
- Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells
- (2009) J. Yun et al. SCIENCE
- Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
- (2009) K. P. Olive et al. SCIENCE
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- Diverse molecular functions of Hu proteins
- (2008) M. N. Hinman et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- The Activated Stroma Index Is a Novel and Independent Prognostic Marker in Pancreatic Ductal Adenocarcinoma
- (2008) Mert Erkan et al. Clinical Gastroenterology and Hepatology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now